Inventor · disambiguated record
Mark J. Macielag
Also filed as: MACIELAG MARK · MACIELAG MARK J · MACIELAG MARK JOSEPH
91 granted patents·25 pending applications·770 citations·filing 1993–2024
99Inventor score
Files withJANSSEN PHARMACEUTICA NV64ORTHO MCNEIL PHARM INC11MACIELAG MARK J7BIAN HAIYAN5CONNOLLY PETER J5
Top patents by PatentIndex Score
116 records- 0198US8426401B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Apr 23, 2013·77 cites·18 claims
- 0297US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0397US8759333B2Di-azetidinyl diamide as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·45 cites·2 claims
- 0497US8741887B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jun 3, 2014·49 cites·4 claims
- 0597US8697684B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·48 cites·4 claims
- 0697US8604017B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 10, 2013·49 cites·4 claims
- 0797US8399454B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Mar 19, 2013·53 cites·17 claims
- 0896US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0995US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 1094US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 1194US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 1294US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 1393US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 1493US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 1592US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
- 1692US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1791US10968264B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·2 cites·31 claims
- 1891US10961293B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 30, 2021·2 cites·14 claims
- 1990US8367653B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Feb 5, 2013·8 cites·19 claims
- 2090US6492358B2β-carboline derivatives useful as inhibitors of phosphodiesteraseORTHO MCNEIL PHARM INC·Filed 2001·Granted Dec 10, 2002·37 cites·14 claims
- 2189US6635638B2Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Oct 21, 2003·31 cites·18 claims
- 2289US2024018208A1Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2388US8809327B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2012·Granted Aug 19, 2014·13 cites·5 claims
- 2488US8362000B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·6 cites·17 claims
- 2588US8153682B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2008·Granted Apr 10, 2012·16 cites·37 claims
- 2687US8748417B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 10, 2014·9 cites·2 claims
- 2786US11230526B1Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 25, 2022·2 cites·25 claims
- 2886US8455476B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Jun 4, 2013·5 cites·30 claims
- 2986US8415341B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsCHEVALIER KRISTEN·Filed 2010·Granted Apr 9, 2013·18 cites·18 claims
- 3086US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3185US8513423B2Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Aug 20, 2013·8 cites·16 claims
- 3285US8362001B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·4 cites·18 claims
- 3385US6864253B2Benzo[4,5]thieno[2,3-c]pyridine and Benzo[4,5]furo[2,3-c]pyridine Derivatives Useful as Inhibitors of PhosphodiesteraseORTH MCNEIL PHARMACEUTICAL INC·Filed 2002·Granted Mar 8, 2005·20 cites·9 claims
- 3484US8445477B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 21, 2013·4 cites·20 claims
- 3584US6765011B27-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormoneORTHO MCNEIL PHARM INC·Filed 2003·Granted Jul 20, 2004·17 cites·14 claims
- 3683US8450303B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 28, 2013·3 cites·17 claims
- 3783US6818646B2Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitorsFiled 2003·Granted Nov 16, 2004·19 cites·2 claims
- 3882US8846655B24-substituted-2-phenoxy-phenylamine delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Sep 30, 2014·7 cites·24 claims
- 3981US8722658B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 13, 2014·2 cites·4 claims
- 4081US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
- 4181US8623858B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 7, 2014·2 cites·4 claims
- 4280US8962607B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·9 claims
- 4380US8691805B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 8, 2014·2 cites·8 claims
- 4480US7732612B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 8, 2010·3 cites·12 claims
- 4580US7179805B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 20, 2007·15 cites·14 claims
- 4679US11732019B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
- 4779US9464055B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·3 cites·16 claims
- 4878US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 4975US9266835B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·2 cites·21 claims
- 5074US8378117B2Hexahydro-cycloheptapyrazole cannabinoid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 19, 2013·2 cites·1 claims
Showing the top 50 of 116 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →